Clinical Cancer Research Joint Metastasis Research Society-AACR Conference on Metastasis Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

Clinical Cancer Research 14, 654-659, February 1, 2008. doi: 10.1158/1078-0432.CCR-07-1577
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Negin, B.
Right arrow Articles by Atkins, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Negin, B.
Right arrow Articles by Atkins, M.

Human Cancer Biology

Effect of Melanoma on Immune Function in the Regional Lymph Node Basin

Benjamin Negin, David Panka, Wei Wang, Mustaqueem Siddiqui, Nicholas Tawa, John Mullen, Steven Tahan, Lucy Mandato, Adam Polivy, James Mier and Michael Atkins

Authors' Affiliation: Cutaneous Oncology Program, Beth Israel Deaconess Medical Center, and Project 5 and the Immune Monitoring and Biostatistics Cores of the Harvard Skin Cancer Specialized Programs of Research Excellence, Boston, Massachusetts

Requests for reprints: Michael B. Atkins, Beth Israel Deaconess Medical Center, Room 412, MASCO Building, 375 Longwood Avenue, Boston, MA 02215. Phone: 617-632-9250; Fax: 617-632-9260; E-mail: MAtkins{at}bidmc.harvard.edu.

Purpose: To determine if melanoma within the tumor microenvironment will result in immunosuppression within the draining lymph node as measured by down-regulation of T-cell receptor {zeta} (TCR {zeta}) expression.

Experimental Design: Patients with clinical stage I to III melanoma undergoing wide local excision and sentinel lymph node biopsy or therapeutic lymph node dissection were consented to have a portion of their lymph node sampled. Lymph nodes were classified as macroscopically involved (TI), microscopically involved (MI), noninvolved with positive wide excision (NI+), or noninvolved with negative wide excision (NI–). Lymphocytes were stained using antibodies to TCR {zeta} and other immune cells and analyzed via flow cytometer. Reverse transcription-PCR was used to assess for mediators of immunosuppression.

Results: Fifty patient lymph node samples (15 TI, 7 MI, 9 NI+, and 19 NI–) were evaluated. Increasing involvement of tumor in the lymph node was associated with decreasing TCR {zeta} chain expression (TI 56%, MI 76%, and NI– 89%). Differences between TI and MI (P = 0.005), TI and NI– (P = 0.0001), and MI and NI– (P = 0.019) were statistically significant. There was also a significant difference between TCR {zeta} chain expression of NI+ and NI– (73% versus 89%; P = 0.0016). A trend toward increased arginase expression in tumor-involved lymph nodes was detected by reverse transcription-PCR.

Conclusions: Melanoma involvement of regional nodes is associated with loss of TCR {zeta} expression that is inversely related to tumor burden. Residual melanoma within the wide local excision specimen is associated with TCR {zeta} loss in noninvolved sentinel lymph nodes, suggesting that immune modulation precedes tumor spread.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2008 by the American Association for Cancer Research.